OBJECTIVE-To identify, localize, and determine M1/M2 polarization of epidydimal adipose tissue (eAT) macrophages (⌽s) during high-fat diet (HFD)-induced obesity.
C
hronic inflammation is a pathogenic factor in obesity complications, in particular insulin resistance (1, 2) . A significant advance in our understanding of obesity-associated inflammation and insulin resistance has been recognition of the underlying role of adipose tissue macrophages (ATM⌽s) (1) (2) (3) (4) . Tissue M⌽s are phenotypically heterogeneous and are broadly characterized according to activation (polarization) state by the M1/M2 classification system (5,6): Classical M1 activation induced by interferon-␥ and lipopolysaccharide (LPS) defines proinflammatory, microbicidal M⌽s. M1 M⌽s are the first line of defense against intracellular pathogens, and they prime toward a Th1 adaptive immune response by producing interleukin (IL)-12 (7) . In contrast, M⌽s expressing one of several overlapping M2 polarization states are activated by IL-4/ IL-13 (M2a or "alternative" activation), diverse stimuli (e.g., apoptotic cells) in concert with LPS (M2b), or IL-10, transforming growth factor (TGF)-␤, or glucocorticoids (M2c). M2-polarized M⌽ function in tissue remodeling during development and in response to injury, and they promote the resolution of acute inflammation. Although M2a polarized M⌽s are also involved in antiparasite defense and Th2 priming, it has been suggested that the predominant role of M2-polarized M⌽s is the regulation of tissue homeostasis (8, 9) . Thus, M2-polarized M⌽s typically upregulate arginase (ARG)-1 and downregulate inducible nitric oxide sythase (iNOS) (thereby promoting collagen production at the expense of microbicidal NO); elevate the expression of inflammation-suppressive factors (IL-10 and IL-1Ra), matrix metalloproteinases (MMPs), and proangiogenic mediators; and express an overall attenuated proinflammatory and Th1-priming gene expression profile.
Our current understanding of how ATM⌽s promote obesity-associated inflammation and insulin resistance is based in large part on the "phenotype switch" model of Lumeng et al. (10) . In this model, obesity promotes the recruitment of M1-polarized ATM⌽s that shift the noninflammatory milieu maintained by M2a polarized, resident ATM⌽s toward a proinflammatory state. In epididymal AT (eAT), these M1 ATM⌽s (eATM⌽s) are distinguished by 1) localization to crown-like structures (CLS) and cell "clusters" of active remodeling around dead adipocytes (7, 11, 12) , 2) elevated expression of the CC chemokine receptor CCR2 and the dendritic cell marker CD11c in conjunction with downregulation of the signature M2 lectin macrophage galactose-type C-type lectin (MGL)1 (11) , and 3) by an M1 gene expression profile featuring upregulated iNOS and downregulated ARG-1 (10, 11, 13) .
The M1 polarization of eATM⌽s is in certain respects counterintuitive. Adipose tissue expansion is a process of coordinated tissue remodeling and repair involving removal of apoptotic cells (adipocytes), extracellular matrix remodeling, angiogenesis, and new adipogenesis (12,14 -16) . In other tissues, these types of remodeling and reparative processes typically involve M2-polarized M⌽s (5, 6) . Moreover, these features of adipose tissue remodeling are manifest in or near the "clusters" to which CCR2 ϩ and/or CD11c ϩ eATM⌽s selectively localize, and roles for clusterassociated eATM⌽s in adipocyte clearance and angiogenesis have been proposed (7, 12, 14) . In humans, fat mass expansion is associated with the accumulation of antiinflammatory or mixed M1/M2-polarized ATM⌽s (17) . These ATM⌽s exhibit "remodeling" phenotypes (18) characterized by increased MMP activities and elevated expression of lymphatic vessel endothelial hyaluronan receptor (LYVE)-1, a mediator of adipose tissue angiogenesis (19) . Considered together, these observations suggest that one or more populations of recruited eATM⌽s are likely to express features of an M2-like remodeling phenotype during the development of murine obesity and insulin resistance.
Here we identify, localize, and transcriptionally characterize eATM⌽ subtypes in mice fed a high-fat diet (HFD) for 8 or 12 weeks, a period of progressively increasing body weight, eAT remodeling, eATM⌽ recruitment, and whole-body insulin resistance (12) . Our observations redefine the phenotypic potential of CD11c ϩ eATM⌽s and suggest that obesity and insulin resistance develop in this model in association with a coincident M2 and M1 phenotypic progression.
RESEARCH DESIGN AND METHODS
Animals and diets. Six-week-old male C57BL/6j mice were fed a low-fat diet (LFD) (10% energy from fat) or an HFD (60% energy from fat) (12) for 8, 10, or 12 weeks at The Jackson Laboratory (Bar Harbor, ME). Following overnight shipment, mice were fed the same diets in a viral pathogen-free facility for 2-3 days before use. Mice fed an HFD for 10 weeks were maintained for an additional 6 days at the Human Nutrition Research Center on Aging on either an HFD or an HFD containing (0.01%, wt/wt) pioglitazone (PIO) (HFDϩPIO). Six-week-old standard diet-fed mice were maintained for an additional 4 weeks on standard diet or HFD following in vivo phagocyte labeling with PKH26 (see below). Mice were killed by CO 2 /cervical dislocation, and eAT was processed as described below. All procedures adhered to Human Nutrition Research Center on Aging Institutional Animal Care and Use Committee Guidelines.
Intraperitoneal insulin tolerance test (ITT).
Whole-body insulin resistance was determined in mice as described (12) . Immunohistochemistry and immunofluorescence. Paraffin sections were probed with goat anti-mouse MGL1 (R&D Systems, Minneapolis, MN) or with IgG isotype control followed by horseradish peroxidase-conjugated second antibody (12) . For immunofluorescence, eAT was fixed in zinc-paraformaldehyde (Zn-PFA) (20) , minced into ϳ1 ϫ 1 ϫ 1 mm pieces, blocked with horse serum, and incubated with MGL1 antibody in PBS/horse serum (o/n, 4°C) followed by DyLight488-conjugated secondary antibody and Hoechst reagent. Stromal vascular cell isolation. eAT was placed into Krebs-Henseleit buffer (21) supplemented with 4% fatty acid-free BSA, 5 mmol/l D-glucose, and 200 nmol/l PIA; minced; centrifuged (500g, 5 min, room temperature); digested (30 -40 min, 37°C) with endotoxin-free Liberase 3 (0.3 units/ml, Roche Applied Science, Indianapolis, IN) containing 50 units of DNase I (Sigma-Aldrich); passed through a sterile 100-m strainer (Fischer Scientific, Franklin, MA); and centrifuged (500g, 5 min, room temperature). Following incubation with erythrocyte lysis buffer, stromal vascular cells (SVCs) were resuspended (1 ϫ 10 6 cells/100 l) in cold fluorescence-activated cell sorting (FACS) buffer (PBS containing 1 mmol/l EDTA, 25 mmol/l HEPES, and 1% [wt/vol] fatty acid-free BSA) until immunolabeling. Flow cytometry and SVC sorting. SVCs were incubated on ice (10 min) with FcBlock (5 g/ml) (BD Pharmingen, San Jose, CA), followed by incubation with fluorophore-conjugated antibodies or isotype controls. Antibodies included phycoerythrin-Cy5-conjugated F4/80 (eBioscience, San Diego, CA), phycoerythrin-conjugated CD11c (BD Pharmingen, Franklin Lakes, NJ), goat anti-mouse MGL1 (R&D Systems), and donkey anti-goat DyLight488 (Jackson ImmunoResearch Laboratories, West Grove, PA). Cells were analyzed using a FACScalibur flow cytometer equipped with CellQuest software (Becton Dickinson, San Jose, CA) or sorted on a MoFlo multilaser system sorter (Beckman Coulter, Brea, CA) using Summit software (Beckman Coulter). Gating and compensation strategies are depicted in Fig. 1 
RESULTS

CD11c
؉ ATM⌽s with differential MGL1 expression levels are recruited to and accumulate in eAT of mice fed an HFD. As reported (12) feeding the HFD for 8 weeks increased body and eAT weights and induced whole-body insulin resistance (Table 1) . Although total SVCs increased in response to HFD, SVCs per gram eAT did not (Table 1) . Flow cytometry (Fig. 1A) confirmed that the preponderance (Ͼ90%) of eATM⌽s (F4/80 ϩ cells) in mice fed a LFD did not express CD11c and that the HFD induced the accumulation of CD11c ϩ eATM⌽s (10) . Overall, there appeared to be a continuum of MGL1 expression rather than distinct populations of MGL1-expressing cells ( Fig.  1A and C) . When gated for MGL1, CD11c ϩ eATM⌽s unexpectedly exhibited a broad distribution of MGL1 staining intensity that partially overlapped that of MGL1 ϩ / CD11c Ϫ cells (Fig. 1A, bottom Table 2 ; quantitative data summarized in Table 2 are presented in supplemental Fig. 2 ). In contrast, MGL1
Ϫ eATM⌽s at HFD week 8 expressed elevated levels of CCR2 and several hallmark M1 transcripts (iNOS and IL-12p40), coincident with reduced expression of some M2 transcripts (IL-13, SPHK1, CD206, and CD163) and increases in M2 genes with inflammation-suppressive functions (IL-10, IL-1Ra, and STAT-6) ( (Table 2 ). CD11c ϩ eATM⌽s also upregulated genes promoting tissue remodeling, including MMP-12 (22) , and a proteinase with a disintegrin and metalloproteinase domain (ADAM)-8, a mediator of Th2-dependent airway remodeling in asthma (23) . CD11c ϩ eATM⌽s also expressed relatively high levels of vascular endothelial growth factor (VEGF), and the MGL1 Ϫ /CD11c ϩ subtype expressed more TGF␤-1 mRNA (Table 2 ). These remodeling signatures were associated with an M2-like expression pattern of several genes, including the upregulation of IL-1Ra interleukin-1 receptor antagonist and the downregulation of the M1-associated genes MCP-1 monocyte chemoatractant protein, caspase-1, and toll-like receptor (TLR)-4.
Both CD11c ϩ subtypes also expressed relatively greater amounts of M1 transcripts with proinflammatory (IL-1␤) and Th1-priming (IL-12p40) functions, and they downregulated several inflammation-suppressive (M2) genes (IL-10, IL-13, and STAT6) and the prototypic M2 markers Ym-1 CD206 and CD163 (Table 2 ). These data are consistent with the reported M1 polarization of MGL1 Ϫ and CD11c ϩ eATM⌽s (10, 11, 24) . However, expression of tumor necrosis factor-␣ and IL-6 were comparable in CD11c ϩ and CD11c Ϫ eATM⌽s (data not shown), perhaps reflecting the induction of these genes in CD11c
Ϫ ATM⌽s by the collagenase procedure (25) . In summary, CD11c ϩ eATM⌽s in mice fed an HFD for 8 weeks express mixed M1 (proinflammatory) and M2 (remodeling) transcriptional profiles. (Fig. 1D, upper panel) , but the proportion of eATM⌽s that were MGL1 ϩ /CD11c Ϫ actually decreased (Fig. 1D, bottom panel) . Of note, MGL1 med / CD11c ϩ eATM⌽s remained the predominant CD11c ϩ eATM⌽ subtype (Fig. 1D) . At HFD week 12 eATM⌽s exhibited global changes in the expression of genes involved in inflammation, antigen presentation, tissue remodeling, and metabolism consistent with increased M2 polarization, especially in the two MGL1-expressing subtypes (supplemental Fig. 3 ). The direction and magnitude of these changes are summarized in Fig. 3 . MGL1 ϩ / CD11c
Ϫ and MGL1 med /CD11c ϩ eATM⌽s upregulated hallmark M2 genes (IL-13, Ym-1, SPHK1, and TGF␤-1), downregulated iNOS, and upregulated the adipogenic metalloproteinase MMP-2 (26) (Fig. 3) . MGL1 med /CD11c ϩ eATM⌽s selectively upregulated LYVE-1 (19, 27) while maintaining relatively high levels of VEGF and MMP-12 ( Fig. 3) . When compared with benchmark M2-polarized (MGL1 ϩ /CD11c Ϫ ) eATM⌽s from mice fed an LFD (Table  3) , MGL1-expressing eATM⌽s in mice fed an HFD for 12 weeks had comparable or a more pronounced M2-like expression profile of genes regulating inflammation, lipid metabolism, tissue remodeling, and antigen presentation. However, they continued to express M1-like levels of CD163, CD206, SPHK1 (reduced), and IL-12p40 (increased) as compared with M2-polarized eATM⌽s from mice fed an LFD (Table 3) .
Feeding the HFD for 12 weeks robustly upregulated the transcriptional coactivator peroxisome proliferator-activated receptor (PPAR)-␥ coactivator (PGC)-1␣ in both CD11c ϩ eATM⌽ subtypes (Fig. 3 ), suggesting enhanced oxidative (i.e., M2-associated) metabolism (28) . At this time, mRNA levels of both PGC-1␣ and PPAR-␣ (but neither PPAR-␥ nor PPAR-␦) were three-to fivefold greater in MGL1 med /CD11c ϩ eATM⌽s than in the other two eATM⌽ subtypes (P Ͻ 0.05) (supplemental Fig. 4 ). CD11c ϩ eATM⌽s expressed relatively less IL-1␤ and genes involved in antigen presentation (I-a, CD80, and CD86) (Fig. 3) . Overall, these results demonstrate M2-like changes in lipid/oxidative metabolism and inflammatory gene expression in CD11c ϩ eATM⌽s between weeks 8 and 12 of HFD. Importantly, when compared with benchmark M2-polarized eATM⌽s (Table 3) 
/CD11c
؉ ATM⌽s preferentially accumulate in eAT of obese mice fed PIO. As both PGC-1␣ and PPAR-␣ are targets of PPAR-␥, it was plausible that the M2-like gene expression changes observed in MGL1 med / CD11c ϩ eATM⌽s between weeks 8 and 12 of HFD (Fig. 3 ) reflected increased PPAR-␥ activation (29) . Accordingly, we phenotyped eATM⌽s from mice maintained on HFD for 10 weeks and then fed either HFD or HFD containing the PPAR-␥/-␣ agonist PIO (HFDϩPIO) for an additional 6 days. PIO treatment significantly ameliorated hyperinsulinemia and upregulated uncoupling protein-1 in eAT (Fig.  4) , confirming PPAR-␥ activation. Coincidentally, mRNA levels of both F4/80 and MGL1 were increased in mice fed HFDϩPIO (Fig. 4) , consistent with the recruitment of M2-polarized eATM⌽s. Unexpectedly, CD11c mRNA levels also increased (Fig. 4) . Flow cytometry revealed a selective increase in MGL1 med /CD11c ϩ eATM⌽s in mice fed HFDϩPIO, resulting in a significant increase in the proportion of CD11c ϩ cells expressing MGL1 (Fig. 4) . These results suggest that MGL1 med /CD11c
ϩ ATM⌽s are preferentially recruited and/or accumulate in eAT of HFD-fed mice in response to short-term systemic PPAR-␥ agonism. Importantly, MGL1 med /CD11c ϩ eATM⌽s from mice fed HFDϩPIO displayed elevated levels of Ym-1, PGC-1␣, and PPAR-␣ (but not PPAR-␥) mRNAs (Fig. 4) . This pattern of M2-associated gene expressions mirrors in part that observed in MGL1 med /CD11c ϩ eATM⌽s from mice fed HFD for 12 weeks (Fig. 3 and supplemental Fig. 4) . Mixed M1/M2 remodeling transcriptional profile in whole eAT during HFD-induced obesity. Finally, we determined a mixed M1/M2 and remodeling transcriptional profile at the tissue level during HFD-induced obesity. Quantitative PCR of selected eAT transcripts indicated that the expression of M2/remodeling genes MGL1, IL-10, IL-13, TGF␤-1, ADAM-8, and MMP-2 increased progressively in eAT during the course of HFD (Fig. 5) . MMP12 mRNA (induced Ն300-fold in CD11c ϩ eATM⌽s) ( Table 3 ) was upregulated ϳ100-and 150-fold in eAT at HFD weeks 8 and 12, respectively (data not shown). As expected, transcript levels of M1 cytokines (IL-12p40, IL-1␤, and tumor necrosis factor-␣) also increased during the HFD time course, but iNOS mRNA levels decreased at week 12 ( Fig. 5) , consistent with downregulation in eATM⌽s (Table 3 and supplemental Fig. 3) . Overall, these data demonstrate progressive, coordinate increases in the expression of both M2/remodeling and M1-associated genes in eAT during the course of HFD-induced obesity and insulin resistance (Table 1) .
DISCUSSION
Employing an established model of HFD-induced obesity (12), we demonstrate that eATM⌽s recruited in response to HFD express mixed M1/M2 and remodeling transcriptional profiles and that these profiles become more M2-like with extended HFD feeding. Human ATM⌽s have recently been shown to express mixed M1/M2 remodeling phenotypes (17, 18) , thus distinguishing them from the M1-polarized eATM⌽s reported for obese mice (11, 24) . By demonstrating the pleiotropic transcriptional profiles of eATM⌽s in murine obesity, the present study suggests previously unappreciated phenotypic and functional commonality between murine and human ATM⌽s in the development of obesity and its complications.
We identified three subtypes of recruited eATM⌽s in mice fed an HFD, including the MGL1 ϩ /CD11c Ϫ and MGL1 Ϫ /CD11c ϩ eATM⌽s that were previously reported to be M2a and M1 polarized, respectively (11) . In contrast to a recent report (30) , our sorting strategy did not identify CD11c Ϫ and CD11c ϩ eATM⌽s as F4/80 lo and F4/80 hi , respectively (Fig. 1A and C) . As expected, interstitial MGL1 ϩ /CD11c Ϫ eATM⌽s were M2 polarized in mice fed an LFD (Table 2) . HFD induced the recruitment of MGL1 ϩ / CD11c Ϫ eATM⌽s expressing an altered M2 transcriptional profile and elevated levels of several M1 transcripts (Table  2) . These recruitment data, obtained in young, lean PKH26-injected mice subsequently fed an HFD differ from results of a prior study (11) 
2 and 1 arrows indicate reduced or increased gene expression, respectively, as compared with MGL1 ϩ /CD11c Ϫ eATM⌽s from LFDfed mice (n ϭ 6) (see online appendix Fig. 2 for quantitative data summarized in this table). Transcript levels designated by different symbols are significantly different (P Ͻ 0.05, ANOVA and Tukey procedure).
preponderance of MGL1-expressing CD11c ϩ eATM⌽s in the present study (Fig. 1) . Occasional eATM⌽s expressing both MGL1 and CD11c were previously identified next to clusters (11) (Fig. 3) . MGL1-expressing eATM⌽s upregulated hallmark M2 genes and downregulated iNOS (Fig. 3) . The MGL1 med / CD11c ϩ subtype additionally upregulated MMP-2, CD163, and LYVE-1 (Fig. 3) and was three times more likely than other eATM⌽ subtypes to stain for the IB4 isolectin (data not shown), a marker of adipogenic and angiogenic activities in eAT of obese mice (14) . The increases in LYVE-1 and MMP-2 mRNAs are intriguing in light of proposed role of LYVE-1 ϩ eATM⌽s in new vessel development during eAT expansion (19) , and the demonstration that MMP-2 is required for diet-induced adipocyte hypertrophy (26) . These observations are consistent with the localization of MGL1 med /CD11c ϩ eATM⌽s to remodeling clusters ( Fig. 2 ) and suggest a functional role in angiogenesis and/or adipogenesis.
An unexpected feature of CD11c ϩ eATM⌽ gene expression at HFD week 12 was the robust upregulation of PGC-1␣ (Fig. 3) (rev. in 34) . Although little is known concerning the role of PGC-1␣ in M⌽ polarization (35) , its role in promoting mitochondrial biogenesis and oxidative metabolism suggests that, similar to PGC-1␤ (28), PGC-1␣-mediated gene expression promotes/maintains the M2 state. MGL1 med /CD11c ϩ eATM⌽s additionally expressed high levels of PPAR-␣ mRNA, suggesting increased fatty acid metabolism and blunted proinflammatory responses to Th1 cytokines (36) . At HFD week 12, both CD11c ϩ eATM⌽ subtypes expressed reduced levels of M1-associated transcripts (iNOS, IL-1␤, I-a, and CD80) as well as ARG-1 mRNA. These reductions suggest a relatively deactivated M2c phenotype, consistent with the elevated IL-10 gene expression observed in eAT at this time (Fig. 5) (12) . Similar downregulation of M1 cytokines, iNOS and ARG-1 is observed in M2c-polarized M⌽s during the reparative phase of murine muscular dystrophy (37) .
Systemic PPAR-␥ activation by thiazolidinediones (TZDs) promotes ATM⌽ recruitment, M2-associated gene expression, and tissue remodeling in eAT of obese rodents (29, 30, 38, 39) . Surprisingly, acute (1-week) exposure to TZDs also increases CD11c mRNA in eAT (38) (Fig. 4) . The seemingly anomalous observation of increased CD11c gene expression in response to M2-polarizing treatment is explained by our demonstration that MGL1 med /CD11c ϩ 
/CD11c
؉ subtype, n ‫؍‬ 6. Similar patterns of gene expression were observed at HFD week 12 ( Fig. 3 and  supplemental Fig. 4 ). *P < 0.05, t test, or ANOVA with Tukey procedure.
eATM⌽s selectively accumulate in eAT of obese mice fed the TZD PIO, a PPAR-␥/-␣ agonist (40) . MGL1 med /CD11c ϩ eATM⌽s in mice fed HFDϩPIO upregulated the M2-associated transcripts Ym-1, PGC-1␣, and PPAR-␣ (Fig. 4 ) similar to MGL1 med /CD11c ϩ eATM⌽s in mice fed an HFD for 12 weeks (Fig. 3 and supplemental Fig. 4 ). These observations support the notion that MGL1 med /CD11c ϩ eATM⌽s become more M2 polarized at HFD week 12 and suggest that PPAR-␥ (and/or PPAR-␣) activation by endogenous ligands contributes to this polarization. TZDs promote insulin sensitivity, in part, by promoting fat oxidation and the remodeling of adipose tissue with additional, small adipocytes (29, 39, 41, 42) . Our data suggest that these actions may be promoted in eAT with minimal inflammatory impact by the selective recruitment of MGL1 med /CD11c ϩ eATM⌽s expressing high levels of IL-13, PGC-1␣, MMP-2, and LYVE-1 and relatively reduced levels of IL-1␤ and IL-12p40 as compared with MGL1 Ϫ / CD11c ϩ eATM⌽s (Table 3) . However, the whole-body insulin-sensitizing effects of PIO also reflect its beneficial actions in multiple cells and tissues, including subcutaneous adipose tissue (39, 41, 42) . Thus, despite increases in MGL1 med /CD11c ϩ at HFD week 12, increased insulin resistance (Table 1) is not totally unexpected at this time given the coincident increase in MGL1 Ϫ /CD11c ϩ eATM⌽s (Fig. 1D ) in the absence of the pleiotropic ameliorative actions of PIO.
In closing, we note that the mixed M1/M2 eATM⌽ phenotypes described above were associated with progressively increasing and coordinate expression of M1 and M2/remodeling genes in whole eAT (Fig. 5) . Multiple eAT cell types, in addition to eATM⌽s, undoubtedly contribute to this mixed inflammatory profile. Nevertheless, our data demonstrate that HFD-induced whole-body insulin resistance (Table 1 ) develops in this model coincident with both an M2 as well as an M1 progression in eAT. This conclusion may reflect our use of a 60% (kcal) HFD, containing 33% more energy from fat than the diet used by Lumeng and colleagues (10, 11) to elucidate the M1 eATM⌽ switch. Although qualitatively identical, the higher fat content may promote more eAT remodeling and may coincidentally attenuate M⌽ proinflammatory signaling (43) . In particular, lipid scavenging by CD11c ϩ eATM⌽s at sites of adipocyte death (7) may render them particularly prone to the M1-inhibiting and/or M2-promoting effects of particular fatty acids (43, 44) . Future studies will address mechanisms by which dietary fat and/or adipose tissue microenvironments shape ATM⌽ polarization and its inflammatory and metabolic sequelae. 
